That's required to get an Emergency Use Authorization (EUA), is supposed to be why Novavax is behind schedule due to other cell culture based manufacturers soak

That's required to get an Emergency Use Authorization (EUA), is supposed to be why Novavax is behind schedule due to other cell culture based manufacturers soaking up resources, and why Emergent BioSolutions has never gotten approval for their Baltimore plant to make Janssen doses. Was in fact shut down, AZ/Oxford production at it canceled, etc. As I understand it the rolling reviews for mRNA vaccine approval are purely a matter of time to prove for real the length of efficacy of them, that's part of the risk/benefit analysis. Can only be done a day at a time....